VivoSim Labs, Inc. Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent
VivoSim Labs, Inc. (VIVS) reported Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent of 6.00% for the 12-month period ending 2026-03-31, per its 10-K filed 2026-07-14.
Financial Statements › Notes › Compensation Related Costs
us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent · last filed 2026-07-14
- VivoSim Labs, Inc. defined contribution plan, maximum annual contributions per employee, percent for fiscal 2026 was 6.00%, a 0.00% change from fiscal 2025.
- VivoSim Labs, Inc. defined contribution plan, maximum annual contributions per employee, percent for fiscal 2025 was 6.00%, a 0.00% change from fiscal 2024.
- VivoSim Labs, Inc. defined contribution plan, maximum annual contributions per employee, percent for fiscal 2024 was 6.00%, a 0.00% change from fiscal 2023.
- VivoSim Labs, Inc. defined contribution plan, maximum annual contributions per employee, percent for fiscal 2023 was 6.00%, a 0.00% change from fiscal 2022.
| Period end | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent 12 month |
|---|---|
| 2026-03-31 | 6.00% 10-K · filed 2026-07-14 |
| 2025-03-31 | 6.00% 10-K · filed 2025-06-05 |
| 2024-03-31 | 6.00% 10-K · filed 2024-05-31 |
| 2023-03-31 | 6.00% 10-K · filed 2023-07-14 |
| 2022-03-31 | 6.00% 10-K · filed 2022-06-10 |
| 2021-03-31 | 6.00% 10-K · filed 2021-06-15 |
| 2020-03-31 | 6.00% 10-K · filed 2020-05-28 |
| 2019-03-31 | 6.00% 10-K · filed 2019-06-03 |
| 2018-03-31 | 6.00% 10-K · filed 2018-05-31 |
| 2017-03-31 | 6.00% 10-K · filed 2017-06-07 |
| 2016-03-31 | 6.00% 10-K · filed 2016-06-09 |
| 2015-03-31 | 6.00% 10-K · filed 2015-06-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |